| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910688456203321 |
|
|
Titolo |
Advances in Precision Medicine Oncology / / Hilal Arnouk, Bassam Hassan, editor |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
London : , : IntechOpen, , 2021 |
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (260 pages) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Sommario/riassunto |
|
Recent advances in precision medicine and immuno-oncology have led to highly specific and efficacious cancer therapies such as monoclonal antibodies and immune checkpoint inhibitors (ICIs). This book provides an up-to-date overview of advances in the field of immuno-oncology. Chapters cover such topics as ICIs and how they mount a robust immune response against cancer cells as well as the response of ICIs to treatment predictive biomarkers and their potential immune-related adverse events (irAEs). Additionally, the book includes a comprehensive review of the powerful FDA-approved therapeutic agent doxorubicin, highlighting the molecular mechanisms behind doxorubicin's drug resistance and critical side effects. |
|
|
|
|
|
|
|
| |